血液中营养与免疫指标对肺癌患者预后价值的研究进展

Research progress of blood nutrition and immune indicators in lung cancer prognosis

肺癌是世界范围内发病率和死亡率最高的恶性肿瘤之一,其预后不仅取决于肿瘤本身及所采用的治疗手段,也与患者的营养与免疫状态密切相关。该文通过回顾国内外研究,综述了目前广泛研究的营养及免疫指标对于肺癌预后的预测价值,旨在在临床实践中寻找最佳的预后指标,为肺癌患者治疗后的精准评估与早期干预给予一定的指导。

Lung cancer ranks among the most prevalent and lethal malignancies globally.Its prognostic outcomes are not only contingent upon tumor characteristics and therapeutic interventions but also intricately linked to the nutritional and immune profiles of patients.This article conducts a thorough review of both domestic and international research,providing a comprehensive synthesis of the prognostic value of widely investigated nutritional and immune indicators in the context of lung cancer.The primary objective is to identify optimal prognostic markers in clinical practice,offering guidance for precise post-treatment assessment and early intervention for lung cancer patients.